Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 3, 2011, Pages 684-690

  Kato, Ken ^a   Muro, Kei ^a,b   Minashi, Keiko ^c   Ohtsu, Atsushi ^c   Ishikura, Satoshi ^d   Boku, Narikazu ^e   Takiuchi, Hiroya ^f   Komatsu, Yoshito ^g   Miyata, Yoshinori ^h   Fukuda, Haruhiko ^d  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

^e SHIZUOKA CANCER CENTER   (Japan)

^f OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

^g HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^h Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

Author keywords

Chemoradiotherapy; Esophageal squamous cell carcinoma; Long term toxicity; Salvage surgery

Indexed keywords

5-FLUOROURACIL; 5-FLUOROURACIL (5-FU); ACUTE TOXICITY; CHEMORADIOTHERAPY; CISPLATIN; COMPLETE RESPONSE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; HYPONATREMIA; MEDIAN SURVIVAL; NEUTROPENIA; PERFORMANCE STATUS; PHASE II; RADIATION PNEUMONITIS; SALVAGE SURGERY; SURVIVAL RATE;

CELLS; CHEMOTHERAPY; PLATINUM COMPOUNDS;

TOXICITY;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CREATININE; FLUOROURACIL; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DEATH; DERMATITIS; DIARRHEA; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS FISTULA; ESOPHAGUS STENOSIS; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HYPONATREMIA; INFECTION; LEUKOCYTE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; NEUTROPHIL; PERICARDIAL EFFUSION; PHARYNGITIS; PHASE 2 CLINICAL TRIAL; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION PNEUMONIA; SKIN DISEASE; SPINAL CORD DISEASE; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE;

EID: 80053578246     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.06.033     Document Type: Article

References (30)

1. The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan 2007 Foundation for Promotion of Cancer Research.
2. N. Ando, T. Iizuka, and H. Ide Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204 J Clin Oncol 21 2003 4592 4596 (Pubitemid 46594032)
3. H. Kato, Y. Tachimori, and H. Watanabe Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection J Surg Oncol 61 1996 267 272 (Pubitemid 26117118)
4. N. Ando, S. Ozawa, and Y. Kitagawa Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 2000 225 232 (Pubitemid 30616724)
5. A. Herskovic, K. Martz, and M. al-Sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
6. J.S. Cooper, M.D. Guo, and A. Herskovic Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1999 1623 1627 (Pubitemid 29211772)
7. A. Ohtsu, N. Boku, and K. Muro Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 17 1999 2915 2921 (Pubitemid 29415253)
8. S. Hironaka, A. Ohtsu, and N. Boku Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2-3NanyM0 squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 57 2003 425 433 (Pubitemid 37040939)
9. Japanese Society for Esophageal Diseases Guidelines for the clinical and pathologic studies on carcinoma of the esophagus 8th ed. 1992 Kanehara Shuppan Tokyo
10. H. Igaki, N. Ando, and H. Kato A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907) [Abstract] J Clin Oncol 26 Suppl 15 2008 4510
11. J.R. Carver, C.L. Shapiro, and A. Ng American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects J Clin Oncol 25 2007 3991 4008 (Pubitemid 47477279)
12. D.L. Friedman, and L.S. Constine Late effects of treatment for Hodgkin lymphoma J Natl Compr Canc Netw 4 2006 249 257 (Pubitemid 44265365)
13. R.M. López, and P.L. Cerezo Toxicity associated to radiotherapy treatment in lung cancer patients Clin Transl Oncol 9 2007 506 512
14. S. Ishikura, K. Nihei, and A. Ohtsu Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus J Clin Oncol 21 2003 2697 2702 (Pubitemid 46606313)
15. S.M. Bentzen, and A. Trotti Evaluation of early and late toxicities in chemoradiation trials J Clin Oncol 25 2007 4096 4103 (Pubitemid 47492954)
16. B.D. Minsky, T.F. Pajak, and R.J. Ginsberg INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174 (Pubitemid 34177421)
17. X. Zhang, K.L. Zhao, and T.M. Guerrero Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer Int J Radiat Oncol Biol Phys 72 2008 278 287
18. T. Nakamura, K. Hayashi, and M. Ota Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer Am J Surg 188 2004 261 266 (Pubitemid 39278283)
19. C. Hennequin, B. Gayet, and A. Sauvanet Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus Int J Radiat Oncol Biol Phys 49 2001 657 664 (Pubitemid 32112193)
20. Y. Tomimaru, M. Yano, and K. Takachi Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy J Surg Oncol 93 2006 422 428
21. S. Hattori, M. Muto, and A. Ohtsu EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer Gastrointest Endosc 58 2003 65 70 (Pubitemid 38208749)
22. K.S. Wilson, and J.T. Lim Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: Goal of cure with organ preservation Radiother Oncol 54 2000 129 134 (Pubitemid 30116763)
23. M. Murakami, Y. Kuroda, and Y. Okamoto Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma Int J Radiat Oncol Biol Phys 40 1998 1049 1059 (Pubitemid 28152919)
24. S.G. Swisher, P. Wynn, and J.B. Putnam Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy J Thorac Cardiovasc Surg 123 2002 175 183
25. B. Meunier, J. Raoul, and E. Le Prise Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus Dig Surg 15 1998 224 226 (Pubitemid 28223151)
26. Y. Tachimori, N. Kanamori, and N. Uemura Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma J Thorac Cardiovasc Surg 137 2009 49 54
27. J. Tepper, M.J. Krasna, and D. Niedzwiecki Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2008 1086 1092
28. V. Gebski, B. Burmeister, and B.M. Smithers Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis Lancet Oncol 8 2007 226 234 (Pubitemid 46291702)
29. L. Bedenne, P. Michel, and O. Bouché Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 2007 1160 1168 (Pubitemid 46640561)
30. M. Stahl, M. Stuschke, and N. Lehmann Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310 2317 (Pubitemid 46218723)